DigestRedComo funciona
Red
/
Empresas
Te
No verificado

Telix Pharmaceuticals Limited

Sobre qué escribimos

BancaBiologíaEconomíaFarmacéuticaSanidad

29 Comunicados de prensa

Ver todos los comunicados de prensa
05/06/2025
Farmacéutica
Sanidad
Telix's Illuccix® PSMA-PET Imaging Agent Approved in Germany
Fuente
Telix Pharmaceuticals Limited
Editor
PR News Wire
1.00
0
04/06/2025
Farmacéutica
Sanidad
Telix's Illuccix® PSMA-PET Imaging Agent Approved in Portugal
Fuente
Telix Pharmaceuticals Limited
Editor
PR News Wire
1.00
0
05/05/2025
Farmacéutica
Sanidad
Telix's Illuccix® PSMA-PET Imaging Agent Approved in the Czech Republic
Fuente
Telix Pharmaceuticals Limited
Editor
PR News Wire
1.00
0
30/04/2025
Farmacéutica
Sanidad
Biología
Illuccix Prostate Cancer PSMA-PET Imaging Agent Approved in Finland
Fuente
Telix Pharmaceuticals Limited
Editor
PR News Wire
1.00
0
28/04/2025
Farmacéutica
Sanidad
Telix's Illuccix PSMA-PET Imaging Agent Approved in France
Fuente
Telix Pharmaceuticals Limited
Editor
PR News Wire
1.00
0
15/04/2025
Farmacéutica
Sanidad
Ciencia
Biología
IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate
Fuente
Telix Pharmaceuticals Limited
Editor
PR News Wire
1.00
0
15/04/2025
Farmacéutica
Sanidad
Illuccix® Prostate Cancer PSMA-PET Imaging Agent Approved in Sweden
Fuente
Telix Pharmaceuticals Limited
Editor
PR News Wire
1.00
0
17/03/2025
Farmacéutica
Sanidad
Biología
Illuccix® Approved for Prostate Cancer Imaging in Brazil: First Marketing Authorization in Latin America
Fuente
Telix Pharmaceuticals Limited
Editor
PR News Wire
1.00
0
12/03/2025
Farmacéutica
Sanidad
Biología
Telix Adds Lead-212 Isotope Production Capability
Fuente
Telix Pharmaceuticals Limited
Editor
PR News Wire
1.00
0
25/02/2025
Farmacéutica
Sanidad
Biología
Illuccix® Prostate Cancer Imaging Agent Approved in Luxembourg
Fuente
Telix Pharmaceuticals Limited
Editor
PR News Wire
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0